Colorectal Cancer Clinical Trials in Texas

Showing 261-261 of 261 trials

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

NCT00120172

Currently there is no one standard of care for older patients with metastatic colorectal cancer. The study will examine the tumor response to capecitabine, oxaliplatin, plus bevacizumab. The study will also gather information on the usefulness and side effects of this treatment combination.

Colorectal CancerNeoplasm Metastasis

Geriatric Oncology Consortium40 participantsStarted May 2005

Mission Hills, California, United States • Washington D.C., District of Columbia, United States • Inverness, Florida, United States +2 more locations

PreviousPage 14 of 14

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Other Conditions in Texas